| Name | Hines Pharmacy |
|---|---|
| Organization Name | Acere Drugs Inc |
| Location | 2301 Bergenline Ave, Union City, New Jersey 07087 |
| Type | Pharmacy |
| Phone | (201) 348-2667 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.
Florida Governor Charlie Crist issued a Proclamation recognizing the outstanding work Healthcare Quality Professionals do for the people of Florida. This proclamation mirrors the sentiments of National Healthcare Quality Week, October 17-23rd, which celebrates the work of Healthcare Quality Professionals in improving patient outcomes and healthcare delivery systems.
Watson Pharmaceuticals, Inc. today confirmed that Actavis South Atlantic LLC, which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Oxymorphone Hydrochloride Extended-release Tablets.
Peptides that target blood vessels in fat and cause them to go into programmed cell death (termed apoptosis) could become a model for future weight-loss therapies, say University of Cincinnati (UC) researchers.
› Verified 3 days ago
| NPI Number | 1770598385 |
| Organization Name | ACERE DRUGS INC |
| Doing Business As | HINES PHARMACY |
| Type | Pharmacy |
| Address | 2301 Bergenline Ave, Union City, NJ 07087 |
| Phone Number | 201-348-2667 |
News Archive
A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.
Florida Governor Charlie Crist issued a Proclamation recognizing the outstanding work Healthcare Quality Professionals do for the people of Florida. This proclamation mirrors the sentiments of National Healthcare Quality Week, October 17-23rd, which celebrates the work of Healthcare Quality Professionals in improving patient outcomes and healthcare delivery systems.
Watson Pharmaceuticals, Inc. today confirmed that Actavis South Atlantic LLC, which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Oxymorphone Hydrochloride Extended-release Tablets.
Peptides that target blood vessels in fat and cause them to go into programmed cell death (termed apoptosis) could become a model for future weight-loss therapies, say University of Cincinnati (UC) researchers.
› Verified 3 days ago
News Archive
A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.
Florida Governor Charlie Crist issued a Proclamation recognizing the outstanding work Healthcare Quality Professionals do for the people of Florida. This proclamation mirrors the sentiments of National Healthcare Quality Week, October 17-23rd, which celebrates the work of Healthcare Quality Professionals in improving patient outcomes and healthcare delivery systems.
Watson Pharmaceuticals, Inc. today confirmed that Actavis South Atlantic LLC, which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Oxymorphone Hydrochloride Extended-release Tablets.
Peptides that target blood vessels in fat and cause them to go into programmed cell death (termed apoptosis) could become a model for future weight-loss therapies, say University of Cincinnati (UC) researchers.
› Verified 3 days ago
Cvs Pharmacy #07400 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4700 Bergenline Ave, Union City, New Jersey 07087 Phone: (201) 867-5900 | |
Cvs Pharmacy #04615 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 714 Summit Ave, Union City, New Jersey 07087 Phone: (201) 866-2892 | |
Walgreens #5333 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3333 Park Ave, Union City, New Jersey 07087 Phone: (201) 558-0094 | |
Myerson Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1019 Summit Ave, Union City, New Jersey 07087 Phone: (201) 865-0844 | |
America's Pharmacy Type: Pharmacy Location: 1500 Summit Ave, Union City, New Jersey 07087 Phone: (201) 867-5153 |